Development of multiple complications in type 2 diabetes is associated with the increase of multiple markers of chronic inflammation.

Journal of Clinical Laboratory Analysis
Jawl-Shan HwangJames T Wu

Abstract

Patients with type 2 diabetes (T2DM) are known at risk for developing cardiovascular disease (CVD), nephropathy, and cancer. We were interested to find out whether multiple markers associated with chronic inflammation are detectable in patients with T2DM and are increased in patients with T2DM who developed additional clinical complications. A sequence of multiple risk markers for atherogenesis, associated with chronic inflammation, was measured in patients with T2DM before and after the development of clinical complications. We found that multiple clinical complications frequently developed simultaneously in patients with T2DM. At the early stage of T2DM, only low levels and low percent elevations of multiple risk markers were detected. However, both the level and the percent elevation of these markers were found to increase with disease progression and the development of clinical complications. We believe that chronic inflammation not only contributes to the pathogenesis of T2DM but also continues to increase in T2DM patients who are developing additional clinical complications. It appears that these multiple markers are potentially useful not only for monitoring the progression of T2DM but also predicting the risk of develop...Continue Reading

References

Jan 14, 1999·European Heart Journal·F LeyvaA J Coats
Jan 14, 1999·The New England Journal of Medicine·R Ross
Feb 11, 1999·The New England Journal of Medicine·C Gabay, I Kushner
Oct 28, 1999·American Heart Journal·J D BeckS Offenbacher
Jul 10, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Tsu-Lan WuJames T Wu
Jul 24, 2003·Circulation·David A Morrow, Eugene Braunwald
Jul 20, 2004·Journal of Internal Medicine·E S LeinonenM-R Taskinen
Jan 22, 2005·Seminars in Nephrology·John Kanellis, Duk-Hee Kang
Jan 28, 2005·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Qiang YaoBengt Lindholm
Feb 1, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Luigi SironiElena Tremoli
Feb 23, 2005·American Journal of Nephrology·Robert A ShortKatherine R Tuttle
May 3, 2005·The Journal of Clinical Investigation·Kathryn E Wellen, Gökhan S Hotamisligil
May 17, 2005·Current Molecular Medicine·D Ziegler
Dec 14, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·James T Wu, Lily L Wu
Aug 4, 2006·The New England Journal of Medicine·Richard N Kitsis, Ishwarlal Jialal

❮ Previous
Next ❯

Citations

May 4, 2010·European Journal of Applied Physiology·Raul A MartinsAna Maria Teixeira
Apr 27, 2011·American Journal of Pharmaceutical Education·Arijana MeštrovićAndreia Bruno
Sep 25, 2009·American Journal of Pharmaceutical Education·Claire Anderson, Billy Futter
Oct 28, 2019·International Journal of Molecular Sciences·Jung-Feng LinFeng-Huei Lin
Dec 25, 2009·Expert Opinion on Pharmacotherapy·Richard Scranton, Anthony Cincotta

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.